RICHMOND, Va., Jan. 05, 2021 Atlantic Union Bankshares Corporation (the “Company”) today announced that it will release fourth quarter and fiscal year 2020
Cullinan Management Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) Cullinan Management, Inc., a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients, announced today the pricing of its upsized initial public offering of 11,900,000 shares of common stock at a price to the public of $21.00 per share. All shares are being offered by Cullinan Management. The gross proceeds to Cullinan Management from the offering, before deducting underwriting discounts, commissions and other offering expenses, are expected to be approximately $249.9 million. In addition, the underwriters have a 30-day option to purchase up to an additional 1,785,000 shares of common stock at the initial public offering price less underwriting discounts and commissions. The shares are expected to begin trading on The Nasdaq Global Select Market un
IPO Alert: Gracell Biotechnologies (GRCL)
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Gracell Biotechnologies is scheduled to make its debut on the Nasdaq Global Select Market today (January 8), under the ticker symbol GRCL.
The Suzhou, China-based Gracell Biotechnologies is a global clinical-stage biopharmaceutical company developing CAR-T cell therapies for cancer through its proprietary technology platforms-FasTCAR and TruUCAR.
The company has offered to sell 11.0 million American depositary shares at a price of $19 per ADS. The underwriters have an option for a period of 30 days to purchase up to an additional 1.65 million ADSs. The aggregate gross proceeds are expected to be $209.0 million. The global offering is scheduled to close on January 12, 2021.
Powered by
Trading on the Nasdaq Global Select Market under the ticker AFRM shares have gained more than 100%. They were up another 41% on Thursday, last trading at $137.51, after pricing at $49 per share.
OATLY
As for consumer deals on the docket, earlier this month, FOX Business exclusively reported that Sweden-based Oatly, which uses oats to make vegan products like oat milk, yogurt, and cheese, is slated to go public sometime this year.
The company, backed by the likes of Oprah Winfrey, Natalie Portman, and rapper Jay-Z’s entertainment company Roc Nation, could raise $1 billion and has reportedly hired Morgan Stanley, JP Morgan Chase and Credit Suisse to advise on the IPO, according to CNBC. Blackstone Group last July led a $200 million round of funding for Oatly.